Clorox (CLX) vs Kenvue (KVUE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Kenvue (KVUE) has outperformed Clorox (CLX) over the past year, gaining 10.3% versus a loss of 30.2%. Kenvue is the larger company by market cap ($33.96 billion vs $10.10 billion), about 3.4 times the size, while Clorox is growing revenue faster (+0.2% vs -2.1%). On valuation, Clorox trades at a lower forward P/E (13.5x vs 14.3x for Kenvue).
Clorox offers the higher dividend yield (5.95% vs 4.69%). Clorox converts more of its revenue into profit, with a net margin of 11.4% versus 9.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLX | KVUE |
|---|---|---|
| Share price | $83.53 | $17.68 |
| Market cap | $10.10B | $33.96B |
| 1-day change | +0.10% | -0.28% |
| YTD return | -17.25% | +2.78% |
| 1-year return | -30.23% | +10.26% |
| 5-year return | -48.89% | — |
| P/E ratio (TTM) | 17.36 | 20.56 |
| Forward P/E | 13.45 | 14.26 |
| EPS (TTM) | $4.81 | $0.86 |
| Dividend yield | 5.95% | 4.69% |
| Annual dividend | $4.97 | $0.83 |
| Revenue (latest FY) | $7.10B | $15.12B |
| Revenue growth (YoY) | +0.16% | -2.14% |
| Net income (latest FY) | $810.00M | $1.47B |
| Gross margin | 45.23% | 58.13% |
| Operating margin | — | 15.96% |
| Net margin | 11.40% | 9.72% |
| 52-week high | $128.90 | $20.13 |
| 52-week low | $79.12 | $14.02 |
| Distance from 52-week high | -35.20% | -12.17% |
| Analyst consensus | hold | none |
| Avg. price target upside | +19.23% | +10.29% |
| Average volume | 2.90M | 21.94M |
| Shares outstanding | 120.94M | 1.92B |
| Employees | 9,200 | 21,780 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Specialty Chemicals | Package Goods/Cosmetics |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Kenvue is about 3.4 times larger than Clorox by market value ($33.96B vs $10.10B).
- KVUE has outperformed CLX by 40.5 percentage points over the past year.
- Clorox offers a meaningfully higher dividend yield (5.95% vs 4.69%).
About Clorox
CLX stock →The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International.
Consumer Discretionary · Specialty Chemicals · 9,200 employees
About Kenvue
KVUE stock →Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America.
Consumer Discretionary · Package Goods/Cosmetics · 21,780 employees
CLX vs KVUE FAQ
Which is bigger, Clorox or Kenvue?
Kenvue (KVUE) is larger, with a market capitalization of $33.96B compared with $10.10B for Clorox (CLX).
Which stock has performed better over the past year, CLX or KVUE?
KVUE returned +10.26% over the past 12 months, compared with -30.23% for CLX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CLX or KVUE?
CLX has the lower trailing P/E at 17.4, versus 20.6 for KVUE. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Clorox or Kenvue?
Clorox has the higher yield at 5.95%, compared with 4.69% for Kenvue.
Are Clorox and Kenvue in the same industry?
Both are in the Consumer Discretionary sector, but in different industries: Specialty Chemicals for Clorox and Package Goods/Cosmetics for Kenvue.